Prosecution Insights
Last updated: October 25, 2026

Hoffman Warnick LLC

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics

53 pending office actions • 25 clients • 51 examiners • 37 art units • 0 of 53 (0%) have an AI response strategy ready

Analysis

HOFFMAN WARNICK LLC has 51 pending office actions in Semiconductors, Circuits & Optics. Its career record includes 10662 applications, showing a large prosecution history in a technology area that often involves complex device, circuit, and optical relationships. The pending docket identifies substantial current examination activity against that historical base.

The resolved allowance rate is 87.11%, and allowed matters have averaged 2.94 office actions. The rate addresses resolved allowance results, whereas the action average describes the response activity associated with successful cases. Portfolio counsel can use the combination to separate outcome assessment from the practical effort required to advance claims through examination.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=10662 apps, methodology: how we score firms)

87.1%
Allowance Rate
n=10662
+0.55σ
Allowance Rate (norm)
n=10662
2.9
OAs to Allowance
n=7337
-0.30σ
OAs to Allow (norm)
n=7337
945 days
Time to Allowance
n=7337
+9.0pp
Interview Lift
n=10662
19.9%
RCE Rate
n=10662
2.4%
Appeal Rate
n=10662

Rejection Performance (% of received rejections ultimately overcome)

81.5%
§101 Overcome
n=648
82.6%
§102 Overcome
n=2972
83.1%
§103 Overcome
n=4637
84.4%
§112 Overcome
n=3324

Specialization & Scale

F01D, F05D, H10D
Top CPC Subclasses
12%
Top-3 CPC Share
n=10662
8
Practitioners
n=10662
1332.8
Apps / Practitioner
n=10662

Portfolio Summary

53
Total Pending OAs
38
Non-Final OAs
14
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
1
Due this week
4
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (1)Due ≤ 30 days (4)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

25
Hard (47%)
26
Medium (49%)
1
Easy (2%)
1
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other5 (9%)
§103 only16 (30%)
§102 only6 (11%)
§112 only1 (2%)
Double-patenting + other4 (8%)
Multi-statute (no §101)19 (36%)
No statute on record1 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
30% of docket
2
Information Tech
4% of docket
0
Communications
0% of docket
21
Semiconductors
40% of docket
12
Mechanical / Eng
23% of docket
2
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

530 h
Manual time on pending OAs
106 h
Time saved (low, 20%)
186 h
Time saved (mid, 35%)
4.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WHITE, DAWANNA SHAR-DAY 2 62.4% +24.3%
VU, STEPHEN A 2 82.1% +14.8%
NICHOLS, PHYLLIS M 1 79.2% +19.6%
HURLEY, SHAUN R 1 77.6% +17.7%
LOPEZ, ERICK I 1 53.4% +29.7%
ALDERSON, ANNE-MARIE K 1 33.1% +41.9%
ROSTAMI, MOHAMMAD S 1 67.0% +25.7%
ZAMAN, SADARUZ 1 46.0% +33.5%
TRAN, MICHAEL THANH 1 95.8% +0.5%
PHAM, LY D 1 94.0% +3.4%

Hard Cases (25)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17200106 MACHINE LEARNING FRAMEWORK FOR CONTROL OF AUTONOMOUS AGENT OPERATING IN DYNAMIC ENVIRONMENT REDA, MATTHEW J 46d overdue
18527638 TREATMENT OF ACUTE ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR KUCKLA, ANNA GRACE 5d overdue
19150156 ACTIVE TEXTILES HURLEY, SHAUN R —
19138640 SYSTEM AND METHOD FOR PROVIDING HOSPITAL CUSTOMER RELATIONSHIP MANAGEMENT CONTENT ALDERSON, ANNE-MARIE K —
19172846 ASYNCHRONOUS DATA SHARING COMPUTING INFRASTRUCTURE ROSTAMI, MOHAMMAD S —
19112421 Kinematic Analysis of Events During Playing of Sports Including Feedback Display ZAMAN, SADARUZ —
19004610 BIT CELL, IN-MEMORY COMPUTING CIRCUIT FOR MAJORITY FUNCTIONS, AND IN-MEMORY COMPUTING METHOD PHAM, LY D —
18961613 LINER DISCHARGE STRUCTURE WITH RIBS GRUBY, RANDALL A —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19269607 PROTECTIVE BATTING GLOVE WITH HAND AND FOREARM GUARD LOPEZ, ERICK I 8d
18249920 TREATMENT OF PUBLIC SPEAKING ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST WHITE, DAWANNA SHAR-DAY 27d
19325642 Valve device, thermal management system, use and method NICHOLS, PHYLLIS M —
19150156 ACTIVE TEXTILES HURLEY, SHAUN R —
19138640 SYSTEM AND METHOD FOR PROVIDING HOSPITAL CUSTOMER RELATIONSHIP MANAGEMENT CONTENT ALDERSON, ANNE-MARIE K —
19172846 ASYNCHRONOUS DATA SHARING COMPUTING INFRASTRUCTURE ROSTAMI, MOHAMMAD S —
19112421 Kinematic Analysis of Events During Playing of Sports Including Feedback Display ZAMAN, SADARUZ —
18839564 TRICHOSTATIN A (TSA) SENSITIVITY IN THE TREATMENT OF TUMORS WHITE, DAWANNA SHAR-DAY —

Client Portfolio (25 clients)

Top Art Units

Art UnitApps
16274
28984
28143
37322
28272
28962
16212
28932
16262
37531

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19325642 Valve device, thermal management system, use and method Btt Solutions Ger GmbH NICHOLS, PHYLLIS M 3753 §102 Non-Final OA — Pending Sep 11, 2025
19150156 ACTIVE TEXTILES Plectrum Ltd. HURLEY, SHAUN R 3732 §102§103§112 Non-Final OA — Pending Jul 22, 2025
19269607 PROTECTIVE BATTING GLOVE WITH HAND AND FOREARM GUARD Sames Media LOPEZ, ERICK I 3732 §103 Final Rejection 8d Pending Jul 15, 2025
19138640 SYSTEM AND METHOD FOR PROVIDING HOSPITAL CUSTOMER RELATIONSHIP MANAGEMENT CONTENT Flyingdoctor Inc. ALDERSON, ANNE-MARIE K 3682 §101 Non-Final OA — Pending Jun 12, 2025
19172846 ASYNCHRONOUS DATA SHARING COMPUTING INFRASTRUCTURE Friction Free Dental, Inc. ROSTAMI, MOHAMMAD S 2154 §101§103 Non-Final OA — Pending Apr 08, 2025
19112421 Kinematic Analysis of Events During Playing of Sports Including Feedback Display Connexa Sports Technologies Inc. ZAMAN, SADARUZ 3715 §101§102§103 Non-Final OA — Pending Mar 17, 2025
19035131 SINGLE ENDED SENSE AMPLIFIER WITH CURRENT PULSE CIRCUIT Globalfoundries U.S. Inc. TRAN, MICHAEL THANH 2827 Other Non-Final OA — Pending Jan 23, 2025
19004610 BIT CELL, IN-MEMORY COMPUTING CIRCUIT FOR MAJORITY FUNCTIONS, AND IN-MEMORY COMPUTING METHOD Globalfoundries U.S. Inc. PHAM, LY D 2827 §102§112 Non-Final OA — Pending Dec 30, 2024
18961613 LINER DISCHARGE STRUCTURE WITH RIBS Freedom Manufacturing LLC GRUBY, RANDALL A 3754 §102§112 Non-Final OA — Pending Nov 27, 2024
18909469 FLEXIBLE CIRCUIT BOARD FOR CHIP INTEGRATION AND ELECTRONIC DEVICE HAVING THE SAME Chipbond Technology Corporation SAWYER, STEVEN T 2847 §102§103 Non-Final OA — Pending Oct 08, 2024
18843986 TOPICAL COMPOSITION FOR TREATING INJURIES OR CUTANEOUS INFLAMMATORY STATES OR PROCTOLOGICAL PATHOLOGIES Sila S.p.A. SAEED, ALI S 1616 §103§112 Non-Final OA — Pending Sep 04, 2024
18839564 TRICHOSTATIN A (TSA) SENSITIVITY IN THE TREATMENT OF TUMORS VANDA PHARMACEUTICALS INC. WHITE, DAWANNA SHAR-DAY 1627 §101§103DP Non-Final OA — Pending Aug 19, 2024
18802210 PIC DIE AND PACKAGE WITH MULTIPLE LEVEL AND MULTIPLE DEPTH CONNECTIONS OF FIBERS TO ON-CHIP OPTICAL COMPONENTS Globalfoundries U.S. Inc. KIANNI, KAVEH C 2874 §103 Non-Final OA — Pending Aug 13, 2024
18791581 GRIPPING TOOL Sky Fabrication Inc. VU, STEPHEN A §102§103§112Other Non-Final OA — Pending Aug 01, 2024
18833597 RECOMBINANT MICROORGANISM FOR PRODUCING THREONINE AND USE THEREOF Langfang Meihua Biotechnology Development Co.,Ltd JONES-FOSTER, ERICA NICOLE §103§112 Non-Final OA — Pending Jul 26, 2024
18781154 MODULAR FLAT WETBLAST NOZZLE The Guyson Corporation Of U.S.A. DION, MARCEL T 3723 §102§103 Non-Final OA — Pending Jul 23, 2024
18754070 TREATMENT OF CIRCADIAN RHYTHM DISORDERS VANDA PHARMACEUTICALS INC. RAMACHANDRAN, UMAMAHESWARI 1627 §112DP Non-Final OA — Pending Jun 25, 2024
18752122 3D/4D AI-INFUSED REASONING AND LOGIC PROGRAMMING PLATFORM Motalen LLC SPIELER, WILLIAM 2159 §101§103§112 Non-Final OA — Pending Jun 24, 2024
18668706 HIGH-DENSITY STACKED CAPACITOR AND METHOD Globalfoundries U.S. Inc. ONUTA, TIBERIU DAN 2814 §103§112 Final Rejection — Pending May 20, 2024
18652776 USE OF TRADIPITANT IN MOTION SICKNESS VANDA PHARMACEUTICALS INC. PIHONAK, SARAH 1627 §103DP Non-Final OA — Pending May 01, 2024
18629598 DEPOT ADMINISTRATION OF ILOPERIDONE VANDA PHARMACEUTICALS INC. HELM, CARALYNNE E 1615 §103 Non-Final OA 42d overdue Pending Apr 08, 2024
18604947 ISOLATION STRUCTURE FOR MULTI-VOLTAGE INTEGRATED CIRCUIT Globalfoundries U.S. Inc. AHMADI, MOHSEN 2896 §103 Final Rejection — Pending Mar 14, 2024
18691650 IDEBENONE DERIVATIVES AND THEIR USE IN TREATING PLANTS Mitorx Therapeutics Limited O DELL, DAVID K 1621 §102§112 Non-Final OA — Pending Mar 13, 2024
18691426 TREATMENT OF SLEEP DISTRUBANCES IN AUTISM SPECTRUM DISORDER PATIENTS VANDA PHARMACEUTICALS INC. SZNAIDMAN, MARCOS L 1628 §103 Non-Final OA — Pending Mar 12, 2024
18596893 MACHINE LEARNING SYSTEM FOR IDENTIFYING AND COUNTERING NON-FRIENDLY RADAR NETWORKS Andro Computational Solutions, LLC CROSS, JULIANA MARIA 3648 §103 Final Rejection 27d Pending Mar 06, 2024
18594074 CAPACITIVE JUNCTION BETWEEN CONDUCTIVE LINE AND CONDUCTIVE PILLAR WITH METHODS TO FORM SAME Globalfoundries U.S. Inc. NETTLES, CORALIE ANN 2893 §103 Final Rejection — Pending Mar 04, 2024
18586666 THREE-DIMENSIONAL INTEGRATED CIRCUIT (3DIC) AND 3DIC DESIGN METHOD AND SYSTEM Globalfoundries U.S. Inc. NGO, BRIAN 2851 §102 Non-Final OA — Pending Feb 26, 2024
18583397 FOLDED CASCODE LOW NOISE AMPLIFIER Globalfoundries U.S. Inc. SPALLA, DAVID C 2893 §102§103 Non-Final OA — Pending Feb 21, 2024
18684397 TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH TRADIPITANT VANDA PHARMACEUTICALS INC. CHEN, PO-CHIH 1621 §112 Non-Final OA — Pending Feb 16, 2024
18435338 PLASMA-ASSISTED WATER TREATMENT SYSTEM FOR ELIMINATION OF PERSISTENT ORGANIC AND INORGANIC WATER CONTAMINANTS Moose Hill Enterprises, Inc. CHIU, TAK LIANG 1779 §103§112 Non-Final OA — Pending Feb 07, 2024
18416466 STRUCTURE AND METHOD FOR AN INDUCTOR HAVING A WINDING WITH A FIRST SEGMENT CONNECTED TO TWO SECOND SEGMENTS Globalfoundries U.S. Inc. PATEL, RAKESH BHASKARBHAI 2843 §102 Non-Final OA — Pending Jan 18, 2024
18415955 STRUCTURE WITH TWO WORK FUNCTION METALS OVER CONDUCTIVE BRIDGE, AND METHOD TO FORM SAME Globalfoundries U.S. Inc. PETERSON, ERIK T 2898 §102§103§112 Non-Final OA — Pending Jan 18, 2024
18578371 Antisense Oligonucleotide (ASO) Gene Inhibition and Treatment VANDA PHARMACEUTICALS INC. TATGE, LEXUS MARC 1637 §103DP Non-Final OA — Pending Jan 11, 2024
18527638 TREATMENT OF ACUTE ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATOR VANDA PHARMACEUTICALS INC. KUCKLA, ANNA GRACE 1626 §102§103Other Final Rejection 5d overdue Pending Dec 04, 2023
18526344 FULLY DEPLETED SEMICONDUCTOR-ON-INSULATOR SWITCH WITH BUILT-IN ELECTROSTATIC DISCHARGE PROTECTION Globalfoundries U.S. Inc. FREY, KIMBERLY NEWMAN 2817 §103 Final Rejection 71d Pending Dec 01, 2023
18565752 METHODS OF SLOWING AN INCREASE IN BRAIN VENTRICULAR VOLUME VANDA PHARMACEUTICALS INC. SAEED, KAMAL A 1626 §102 Non-Final OA — Pending Nov 30, 2023
18565690 METHODS FOR TREATING MULTIPLE SCLEROSIS VANDA PHARMACEUTICALS INC. GONZALEZ, LUISALBERTO 1624 §102§103 Non-Final OA — Pending Nov 30, 2023
18515375 STRUCTURE AND METHOD FOR INDUCTOR WITH WINDINGS HAVING DIFFERENT WIDTHS Globalfoundries U.S. Inc. HINSON, RONALD 2837 §102§103 Non-Final OA — Pending Nov 21, 2023
18509669 GRIPPING TOOL Sky Fabrication Inc. VU, STEPHEN A 3654 §102§112Other Non-Final OA — Pending Nov 15, 2023
18249920 TREATMENT OF PUBLIC SPEAKING ANXIETY WITH AN ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST VANDA PHARMACEUTICALS INC. WHITE, DAWANNA SHAR-DAY 1627 §103DP Final Rejection 27d Pending Oct 18, 2023
18478452 SILICON CARBIDE CHANNEL WITH CAPPING SEMICONDUCTOR HAVING HIGHER CHARGE CARRIER MOBILITY Globalfoundries U.S. Inc. RAHMAN, MOIN M 2898 §102 Non-Final OA — Pending Sep 29, 2023
18453390 STRUCTURE WITH GUARD RING BETWEEN TERMINALS OF SINGLE PHOTON AVALANCHE DIODE PHOTODETECTOR AND RELATED METHOD Globalfoundries Dresden Module One Limited Liability Company & Co. Kg HOANG, DZUNG T 2898 §103 Non-Final OA — Pending Aug 22, 2023
18359059 CAVITY WITH NEGATIVE SLOPED SIDEWALL OVER GATE AND RELATED METHOD Globalfoundries Singapore Pte. Ltd. VALENZUELA, PATRICIA D 2812 §103 Non-Final OA 14d Pending Jul 26, 2023
18257699 IMPROVEMENTS IN ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE The University of Liverpool CHUNG, HOSUNG CHARLES 1794 §103 Non-Final OA — Pending Jun 15, 2023
18332147 CAVITY WITH BOTTOM HAVING DIELECTRIC LAYER PORTION OVER GATE BODY WITHOUT ETCH STOP LAYER AND RELATED METHOD Globalfoundries Singapore Pte. Ltd. LUKE, DANIEL M 2896 §102 Final Rejection — Pending Jun 09, 2023
18324249 AI PLATFORM FOR PROCESSING SPEECH AND VIDEO INFORMATION COLLECTED DURING A MEDICAL PROCEDURE Utech Products, Inc. PATEL, JAY M 3681 §103§112 Non-Final OA — Pending May 26, 2023
18195613 ARTIFICIALLY INTELLIGENT EMERGENCY RESPONSE SYSTEM Deep Detection LLC NGUYEN, TAN D 3600 §101§103 Final Rejection — Pending May 10, 2023
18302349 SYSTEM FOR IMAGING SUBSTRATE SURFACE AND RELATED METHOD Globalfoundries U.S. Inc. GARBER, ERIN R 2878 §103 Final Rejection — Pending Apr 18, 2023
18174006 Mollusc Barrier Doff Portland Limited NGUYEN, JOHN P 1619 §103 Non-Final OA — Pending Feb 24, 2023
18169304 STANDARD CELL AND IC STRUCTURE WITH TRENCH ISOLATION THROUGH ACTIVE REGIONS AND GATE ELECTRODES Globalfoundries U.S. Inc. BERRY, PAUL ANTHONY 2898 §103 Non-Final OA — Pending Feb 15, 2023

View all 53 →

Managing Hoffman Warnick LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Hoffman Warnick LLC's patent allowance rate?

87.1% of resolved applications prosecuted by Hoffman Warnick LLC were allowed, across 10,662 applications in USPTO records.

How many office actions does Hoffman Warnick LLC average before allowance?

2.94 office actions per allowed application on average.

How many pending office actions does Hoffman Warnick LLC have?

53 pending office actions as of October 2026, for 25 clients, before 51 examiners in 37 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month